| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cacciatore B et al. | Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. | 2001 | Am. J. Obstet. Gynecol. | pmid:11303197 |
| pmid:11293581 | ||||
| Boyd RA et al. | Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. | 2001 | Contraception | pmid:11292470 |
| Elomaa K et al. | The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. | 2001 | Contraception | pmid:11257243 |
| Saha A et al. | Effects of oral contraceptive norethindrone on blood-lipid and lipid peroxidation parameters. | 2000 Nov-Dec | Acta Pol Pharm | pmid:11243250 |
| Garceau RJ et al. | Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. | 2000 | Contraception | pmid:11239615 |
| Dören M et al. | Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2001 | Fertil. Steril. | pmid:11239541 |
| Perera M et al. | The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11238498 |
| pmid:11237600 | ||||
| Aisaka K | [Add back therapy for patients with endometriosis]. | 2001 | Nippon Rinsho | pmid:11235150 |
| Kamischke A et al. | Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11232016 |
| Weiner E and Johansson ED | Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate. | 1975 | Contraception | pmid:1122756 |
| Slick GL et al. | Hypertension, renal vein thrombosis and renal failure (occurring in a patient on an oral contraceptive agent). | 1975 | Clin. Nephrol. | pmid:1122661 |
| Rozenberg S et al. | Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. | 2001 | Int J Gynaecol Obstet | pmid:11226444 |
| Rockson SG et al. | Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension. | 1975 | Circulation | pmid:1122595 |
| Saltevo J et al. | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. | 2000 | Diabetes Obes Metab | pmid:11225744 |
| Wu Z et al. | Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. | 2000 | Analyst | pmid:11219053 |
| Bhathena RK | The long-acting progestogen-only contraceptive injections: an update. | 2001 | BJOG | pmid:11213001 |
| Koch P | Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. | 2001 | Contact Derm. | pmid:11205390 |
| Ursic-Vrscaj M et al. | Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. | 2001 Jan-Feb | Menopause | pmid:11201519 |